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ABSTRACT 
Investigating the Interactions between Cytokines Interleukin-1 and Interleukin-6.  
(April 2010) 
 
 
Mithil Chokshi 
Department of Biomedical Engineering 
Texas A&M University 
 
 
Research Advisor: Dr. Arul Jayaraman 
Department of Chemical Engineering 
 
 
The purpose of this research project is to study the signaling pathways of the 
inflammatory cytokines – Interleukin-1 (IL-1) and Interleukin-6 (IL-6) – and investigate 
any “cross-talk” between the two. IL-6 plays a central role in the Non-Alcoholic Fatty 
Liver Disease (NAFLD) and we hypothesize that the progression of NAFLD is caused 
by the imbalance in downstream transcription factor activity of IL-1 and IL-6. Thus, 
investigating the possible cross-talk would be beneficial in assessing this imbalance. 
According to the previous work done by the research group, green fluorescent protein 
(GFP) reporter plasmids with STAT3 and C/EBPβ transcription factor binding 
sequences were transfected into human hepatocarcinoma (HepG2) cells. Once they were 
stimulated with cytokines IL-6 or IL-10, they were analyzed with fluorescence 
microscopy which showed that the transcription factors STAT3 and C/EBPβ were 
activated leading to a corresponding expression of GFP. This research project will be 
focused on the dynamics of IL-6 and the effects of IL-1 (instead of IL-10) on it. IL-1 and 
IL-6 are both involved in many inflammatory responses of the body and by having a 
deeper understanding about their pathways to initiation of the inflammatory responses 
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and any interconnections will help us model a feedback system to control the response. 
The findings will assist in finding a therapeutic approach to mitigate various 
inflammatory diseases where IL-1 and IL-6 play a major role in (e.g. NAFLD). In 
addition, these results will also be useful in bioengineering. Inflammatory response of 
the body towards any bioengineered implants mediated by these cytokines could be 
controlled on a molecular level. Thus, instead of wasting thousands of dollars on coming 
up with a new design, bioengineers can manipulate the body’s response and use the 
device that was formerly rejected by the body. Research will be conducted to 1) quantify 
the transcription factor activity, 2) study the dynamics of the transcription factor activity 
under varying conditions, and 3) isolate the pathways and monitor the effects of the 
cytokines on each of pathway. This approach, which is based on Systems Biology, is 
about putting together rather than taking apart, integration rather than reduction. Thus, 
once we have researched the above three factors, we can put them together to 
hypothesize and test the cross-talk. 
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NOMENCLATURE 
C/EBPβ     CCAAT Enhancer Binding Protein-Beta  
ERK  Extracellular-signal Related Kinase 
GDP/GTP Guanosine Diphosphate/ Guanosine Triphosphate 
GFP Green Fluorescence Protein 
GP130 Glycoprotein 130 
Hr Hour 
HepG2 Human Hepatocellular Carcinoma (cell line) 
IL-1 Interleukin 1 
IL-6 Interleukin 6 
JAK Janus Kinase 
JNK c-Jun N-Terminal Kinase 
MEK Map-Erk Kinase 
NAFLD                                     Non-Alcoholic Fatty Liver Disease 
NF-IL6 C/EBPβ 
OSM                                         Oncostatin M 
Raf-1  Proto-Oncogene Serine/Threonine-Protein Kinase 
SOS-1   Son of Sevenless Homolog-1 Protein 
STAT3   Signal Transducer and Activator of Transcription-3 
TF                                             Transcription Factor 
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CHAPTER I 
INTRODUCTION 
The main purpose of this research would be to study the pathways to inflammation 
regulated by IL-6 and to investigate the effects of the cytokine IL-1 on it (interactions 
between IL-1 and IL-6) by measuring the transcription factor activity associated GFP 
expression. IL-1 is a pro-inflammatory cytokine and IL-6 is a pleiotropic cytokine that 
has both pro- and anti-inflammatory actions.  Inflammation is the response of the tissue 
to injury and is characterized in the acute phase by increased blood flow and vascular 
permeability along with the accumulation of fluid, leukocytes, and inflammatory 
mediators such as cytokines [1]. One of the purposes of researching IL-6 is that, it is 
responsible for signaling in the Non-alcoholic Fatty Liver Disease. IL-6-type cytokines 
IL-6, IL-11, LIF (leukemia inhibitory factor), OSM (oncostatin M), ciliary neurotrophic 
factor, cardiotrophin-1 and cardiotrophin-like cytokines are an important family of 
mediators involved in the regulation of the acute-phase response to injury and infection 
[2]. The acute phase response up- or down-regulates the expression of certain plasma 
proteins that take part in the body’s response to the injury-induced inflammation [3]. IL-
6 is responsible for inflammation of liver on injury, or as in this case, for accumulation 
of fat. 
 
 
____________ 
This thesis follows the style of BMC Systems Biology. 
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The importance of this research is that if one is able to figure out a link between IL-6 
and IL-1 signaling pathways, then one can indirectly alter the IL-6 pathway, 
simultaneously altering the IL-1 pathway, and thus control the unwanted inflammatory 
responses of the body. These findings will help to find a solution to inhibit the triggers to 
several inflammatory diseases wherein, IL-1 and IL-6 play an important role leading to 
inflammation. According to the Nutrition Review, since this early study, a long list of 
pro-inflammatory cytokines has been shown capable of stimulating osteoclastic bone 
resorption including interleukin (IL)-1, tumor necrosis factor alpha (TNF-α), IL-6, IL-
11, IL-15, and IL-17 [1]. Systemic inflammatory mediators, such as the cytokines 
interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF) … play an 
important role in the induction of the inflammatory acute phase response (APR) in the 
liver upon trauma or injury [4]. Thus, IL-1 and IL-6 mediate important inflammatory 
responses at various places in the body and isolating the pathways to inflammation 
would be a valuable progress towards understanding and further manipulating these 
responses. 
 
Detailed description of the IL-6 pathways is out of the scope of this paper, but a brief 
description of it is as follows (See Figure 1). IL-6-type cytokines exert their action via 
the signal transducers gp (glycoprotein) 130, LIF receptor and OSM receptor leading to 
the activation of the JAK/STAT (Janus kinase/signal transducer and activator of 
transcription) and MAPK (mitogen-activated protein kinase) cascades [5]. Then it leads 
to the transcription of STAT3 and C/EBPβ.   
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Figure 1: IL-6 signaling pathway[6]. 
 
 
 
Interleukin-1 (IL-1) is a pro-inflammatory cytokine that has several effects in the 
inflammation process. When it binds to its cell-surface receptor, IL-1 initiates a 
signaling cascade that leads to activation of the transcription factor NF-kB and is relayed 
through the protein TRAF6 and a succession of kinase enzymes, including NF-kB-
inducing kinase (NIK) and IkB kinases (IKKs) [7]. 
 
 
 
 
 
 
4 
 
 
 
Project description 
 
Figure 2: Simplified version of what this research is about. Gene product picture, courtesy of Google [8]. 
 
 
 
Based on the details of the pathways, we have hypothesized that since both the signaling 
cascades have the mitogen activating protein kinase (MAPK) as an intermediate in one 
of their pathways, there is a possibility that we can find a way to control MAPK pathway 
in IL-6 with the help of IL-1. This will be done by stimulating the HepG2 cell line with 
IL-1 and IL-6 and then analyzing the intensity of the fluorescence to calculate the 
amount of gene expression under different conditions (concentration, time duration etc.). 
These conditions would be changed time-to-time and is expected to show some 
significant changes in gene expression. These changes would be further analyzed with 
the help of mathematical models used by the research group in order to find the 
dominant conditions which lead to the most expression. This is just one of the many 
possibilities that this research will explore. (See Figure 2). “Cross-talk” between IL-1 
and IL-6 is very possible because these two cytokines are coexpressed at many sites of 
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inflammation [9,10,11]. The evidence presented herein demonstrates that … IL-1 and 
TNFα modulate activation of the Jak-STAT signaling pathway by the pleiotropic 
cytokines related to IL-6 that use the gp130 signaling receptor subunit [12]. According 
to few other studies conducted on various interactions between many pro- and anti- 
inflammatory cytokines in the body, pro-inflammatory cytokines are able to suppress the 
anti-inflammatory cytokines at the level of signal transduction. One such model based on 
the research published in journal of immunology is depicted in Figure 3 below, and it 
shows the inhibition of activation of Stat3 genes by one of the pathways of IL-1 signal 
transduction cascade. However, many of these inhibitory effects on signal transduction 
are cell-type specific…[12], so this model is not necessarily true for this research. 
 
 
Figure 3:  Model for the complex interactions of IL-1 and IL-6. IL-1 blocks Stat3 activation and thus 
inhibits expression of genes that are strongly dependent on Stat3 for expression. In contrast, genes that are 
repressed by Stat3 would be expressed to a higher level in the presence of IL-1. In addition, IL-6 signaling 
pathways other than the STAT pathway may not be suppressed by p38 and may work together with IL-1 
signaling pathways to coactivate certain genes [12]. 
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CHAPTER II 
METHODS 
This chapter of the research is dedicated to the development of the reporter system and the 
fluorescence microscopy method to measure fluorescence. This fluorescence was then analyzed 
by the MATLAB programs in order to quantify it and determine the dynamics of transcription 
factor activity over time. 
 
Principle of GFP reporter system  
As shown in Figure 4 below, a low half-life (2hr) GFP was cloned into a plasmid under 
the control of a minimal promoter (CMVmin). When a TF bound to its upstream 
recognition sequence, the promoter was activated and GFP was expressed.  
 
 
Figure 4: Principle of GFP reporter systems. 
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Reporter cell line generation 
Reporter plasmids for monitoring activation of STAT3 and C/EBPβ were introduced into 
HepG2 cells by electroporation. Approximately 5 x 106 cells were mixed with 10 µg of 
linearized plasmid (pSTAT3-d2egfp or pC/EBPβ-d2egfp) in a pre-chilled sterile 4-mm 
electroporation cuvette and electroporated at 240V and 950 µF. Growth media (600 µL) 
was immediately added to the cells after electroporation and allowed to sit for 10 min at 
room temperature. The mixture was transferred to a 10 cm tissue culture dish and 
incubated for 2 days prior to addition of 800 µg/mL of G418 as selection pressure. 
Surviving colonies (i.e., cells with the STAT3 or C/EBPβ reporter plasmid integrated 
into their genome) were selected and screened for induction of STAT3 or C/EBPβ 
activity after 3 weeks. 
 
Fluorescence microscopy 
HepG2 reporter cell lines for STAT3 and C/EBPβ were seeded in 24-well plates and 
exposed to different concentrations of the cytokines. The cell culture plate was placed on 
the incubated stage of a Zeiss Axiovert 200M fluorescence microscope where constant 
temperature and CO2 levels of 37  C and 5% respectively, were maintained for HepG2 
cells. Phase and fluorescence images were taken every 45 minutes for 24 hrs. 
Fluorescence images were analyzed by MATLAB to obtain the dynamic profiles of 
STAT3 and C/EBPβ activation and then compared with a model derived from the TF 
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calculation. The schematic on page 8 explains the signal transduction model that is 
followed for the experiments performed in this research. 
 
Figure 5: Scheme to calculate TF data from GFP data: Relationship between input, output, and 
concentration of transcription factors with GFP-reporter systems. 
 
 
 
The above mentioned model in Figure 5 has been used for all the experiments thus far, 
with the different cytokines used – IL1, IL6, and OSM. Within five minutes after the 
stimulation of the cells in the plate, the plate is staged in the incubated chamber of the 
microscope. A PH2 condenser is used with the 20x lens used to image the cells. The 
images are focused and saved and then refocused and saved again after 20 minutes and 
the experiment is setup to run for 24hr period. The microscope exposes the cells to the 
normal transmitted light and also to UV light (blue) at the saved positions and it does 
this to each saved position for thirty-three times over the twenty-four hour period. If the 
signaling pathway is stimulated, the GFP is expressed and a picture of this expression is 
saved with every exposure. This pictorial data is then fed into the MATLAB program 
 
IL‐6 
??? 
Signal Transduction Model 
Dynamics of GFP due to activation of C/EBPβ or 
STAT3 
Experimental Results 
STAT3 or C/EBPβ Fluorescence 
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which analyzes, quantifies, and draws a profile of expression like depicted in graphs on 
page 15. 
 
Gel electrophoresis and immunoblotting 
In this part of the project, the actual cross-talk proposed thus far was tested. Literature 
for cytokine research has shown that, the C/EBPβ pathway is inhibited with 
pharmacological inhibitors like U0126 [13]. U0126 was added at different time points to 
the cells and then the cells were lysed with a lysate and the protein inside it was 
fractionated and then a gel electrophoresis was ran on it in order to determine the 
presence of C/EBPβ in the cells. According to the hypothesis, there should be no 
C/EBPβ present in the cells but it was not entirely true in this case. The band for C/EBPβ 
was still present in the final image, but the expression was lower than usually seen 
without U0126. This led to further three hypotheses: 1) There is a possibility that the 
U0126 is not as effective and potent for HepG2 cells; 2) The C/EBPβ activity is 
inhibited but there can be some other intermolecular event leading to a change in 
conformation that is making the U0126 less effective; 3) There is some unknown factor, 
in the serum that is activating the pathway. In order to test these considerations, it was 
decided to use a different inhibitor; to speculate other possible intermolecular events that 
would explain this behavior; and to image the cells in a serum free media in order to 
know any effects that the serum might have on U0126 during which, it is effective. The 
runs for gel electrophoresis are shown in figure on page 20. 
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CHAPTER III 
PRELIMINARY RESULTS AND DISCUSSION 
In order to correctly understand the working of the microscope that the Jayaraman group 
possesses, the group was given a special lecture on the proper usage of the microscope 
and the proper ways image culture cells. The different techniques that are necessary to 
acquire optimum images of the cell culture, including Kohler Illumination, was taught 
and practiced. The designed and planned experiments were then carried out every time 
using the established standard protocol for the microscope use. 
 
In order to first test the methodology of using the fluorescence microscopy and the 
experiment design, a test experiment of stimulation was performed on the Hela cells 
stimulated with Doxycyclin. They were used since HepG2 tend to grow in clumps while 
one can see individual cells with Hela cells; also, cytokines are mighty expensive when 
compared to Doxycyclin. The cells were stimulated with Doxycyclin, commonly used 
for treating various resistant infections. The resultant expression is shown in Figure 7. 
Three different concentrations of Doxycyclin were used – 1ng/mL, 10ng/mL, 100ng/mL 
– per well for each well in a 24 well plate (only 12 wells were used in this case). (See 
Figure 6). 
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Figure 6: This figure shows the 24 well plate used for the experiments throughout this research project. 
Sometimes only 12 wells are used instead all the 24 wells. An example experimental setup will be 12 
wells – A1 to A3, B1 to B3, C1 to C3, and D1 to D3 – of the plate containing Hela cells, and Doxicyclin 
added to B1 to B3 at 1ng/mL, C1 to C3 at 10ng/mL, and to D1 to D3 at 100ng/mL, while A1 to A3 are 
control. 
 
 
The cells are fed with the Hela media every 48 hours and after an approximate 
confluence of 90%, the plate is ready for the experiment. 24 hours prior to an 
experiment, the cells are fed again. Approximately 5-8 minutes before the experiment, 
the cells in the plate are stimulated with the Doxycyclin and then used for the 
experiment. The experiment is run for 20 to 24 hours during which the microscope 
acquires phase contrast and fluorescence images of the cells. The fluorescence images 
are then analyzed by the MATLAB program written by the graduate students. This 
MATLAB program gives us the kinetics of the transcription factor activity related 
expression of GFP over the duration of the experiment. 
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Fluorescence images observed over a period of 24hrs following the stimulation: 
1ng/mL 
 
 
10ng/mL 
 
100ng/mL 
        
Figure 7: The expression resulting from the stimulation of the Hela cells with Doxicyclin. A represents 
the image at 0 hr, B after 11 hrs, and C after 24 hrs. 
 
 
Since the kinetics, the graphs of fluorescence versus time, of the Hela with Doxycyclin 
are of no significant importance to this research, they are not reported.The exact same 
procedure was followed to investigate the kinetics of the HepG2 cells when stimulated 
with cytokines OSM, and IL1. The experiment with the HepG2-C/EBPβ with OSM 
A B C
A B C
A B C
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stimulation was performed twice; the experiment with the HepG2-C/EBPβ with IL1 
stimulation was performed thrice; the experiment on HepG2-STAT3 with IL1 
stimulation was performed once. 
 
The experimental setup is shown in Figure 8 below. The microscope also has an 
incubated chamber where the temperature and carbon-dioxide concentration is 
maintained throughout the experiment. 
 
Figure 8: The schematic of the experiment facility. The plate is staged inside the incubated chamber. 
 
 
 
HepG2 – STAT3 and C/EBPβ – cytokine stimulation 
The HepG2-C/EBPβ were stimulated with OSM at 1ng/mL, 10ng/mL, and 100ng/mL 
dilutions in a 24 well plate followed by an experiment. The HepG2-C/EBPβ were also 
stimulated with IL1 at 1ng/mL, 10ng/mL, and 100ng/mL dilutions in a 24 well plate 
followed by an experiment. In order to observe any change in kinetics, three other 
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concentrations – 0.5ng/mL, 0.05ng/mL, and 0.01ng/mL – of the cytokines were also 
used but the resultant intensity does not vary by an appreciable amount. Finally, HepG2-
STAT3 were stimulated with three different concentrations – 1ng/mL, 10ng/mL, and 
100ng/mL – of IL1.  Figure 9 below shows the fluorescence images and the profile of 
the kinetics followed with different stimulations. 
 
Fluorescence images observed over a period of 24hrs following the stimulation: 
1ng/mL 
 
10ng/mL 
 
100ng/mL 
        
Figure 9: The expression resulting from the stimulation of the HepG2 cells with IL1. A represents the 
image at 0 hr, B after approximately 12 hrs, and C after 24 hrs. 
A
A
A
B
B C
B
C
C
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Dynamic profile of the transcription factor activity: 
 
Figure 10: The fluorescence images and the profiles shown above display the kinetics of the experiment 
on HepG2-C/EBPβ with OSM. 
 
 
 
When comparing the above shown dynamics (see Figure 10) to the model described 
before in Figure 5, one may notice that the theoretical model and the experimental 
results are in excellent agreement with each other. Thus, we have developed HepG2 
reporter cell line with which we can isolate each of the pathways initiated by the 
cytokines IL-1 and OSM, and we can quantify the transcription factor activity with it. 
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This gives a powerful tool to develop a feedback system that will help model the activity 
of any transcription factor related to any cytokine. 
 
The kinetics of HepG2 C/EBPβ with IL-1 were also plotted after the fluorescence 
microscopy experiment conducted on it. Figure 11 shows the profile of GFP expression 
over the duration of the experiment for HepG2 C/EBPβ when stimulated with IL-1. The 
transcription factor activity increased steadily with time and after about eleven hours, it 
stabilized. The graph also shows error bars on it and one can notice that the maximum 
error for this experiment was less than 5 units of intensity at any given time point. In 
order to see if there is any change in the transcription factor activity kinetics, two 
additional 24hr experiments were conducted to monitor the expression when stimulated 
with 0.01, 0.05ng/mL, and 0.5ng/mL of cytokine IL1. However, as one can see from the 
profiles on page 18, there was no significant change in the profile, and thus the activity 
of transcription factor. (See Figure 12).  
 
The expression kinetics correspond to the transcription factor activity explained in the 
Chapter II. 
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Fluorescence images observed over a period of 24hrs following the stimulation: 
1ng/mL 
 
10ng/mL 
 
100ng/mL 
 
Figure 11: The expression resulting from the stimulation of the HepG2-C/EBPβ cells with IL1. A 
represents the image at 0 hr, B after approximately 12 hrs, and C after 24 hrs. 
 
 
 
 
A 
A 
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Dynamic profile of the transcription factor activity: 
          
Figure 12: The kinetics followed by the experiment with HepG2-C/EBPβ and IL1 at different 
concentrations. This data set shows less than one unit of error in intensity and represents the best data our 
experiments have produced. 
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U0126 stimulation 
Plate 1: 
 
 
 
 
 
 
Plate 2: 
 
 
 
 
 
 
Figure 13: Conditions for gel electrophoresis runs. 
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Gel Electrophoresis Images: 
 
 
 
Figure 14: The gel electrophoresis runs are shown in this figure. 
Gel 1 
Gel 2 
C/EBPβ 
50kDa 
C/EBPβ 
50kDa 
Bands:        1         2          3          4         5       6          Standard 
Bands:        1         2          3          4         5       6   Standard 
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There were two gels that were run for testing the hypothesis of knocking down the 
expression of the C/EBPβ pathway with the help of U0126. However, because of the 
before speculated reasons, U0126 did not completely knock down the expression, which 
can be seen from gel electrophoresis images. (See Figures 13 and 14). The expression 
should have increased as usual for about 10hrs and then completely knocked down to 
zero. Instead we see that the expression was lowered to a certain extent. 
Fluorescence images observed over a period of 24hrs following the stimulation: 
 
 
Figure 15: This figure shows fluorescence of C/EBPβ with IL-1 and U0126 over 24hrs. 
 
 
 
In order to verify the Gel runs with U0126, a fluorescence microscopy experiment was 
conducted with C/EBPβ stimulated with U0126 present simultaneously with IL-1. (See 
Figure 15). The expected output would be zero fluorescence over the duration of the 
experiment but as seen from the Figure 15 above, there was some fluorescence after 10 
and 24 hour period. This is also what is seen from the Figure 14, which shows the 
C/EBPβ activity still present even though the cells were stimulated with U0126 but to a 
lesser extent. This expression can be compared with the expression in Figure 11, which 
was the same stimulation, but without U0126. 
A B C
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Raf-1 involvement 
Recent studies conducted with HepG2 cells for the C/EBPβ pathway has revealed other 
ways by which the pathway gets activated.  Of 71 apoptosis-associated genes, c-raf-1 
and S6 were up-regulated in 42.9% and 32.1% of 28 cirrhosis tissues, respectively, and 
both genes were well correlated in a five-cluster K-means analysis. For c-raf-1 and 
downstream genes in the MAPK pathway, c-raf-1, MEK, and MAPK were up-regulated 
in 40%, 80%, and 86.7% of 45 cirrhosis specimens, respectively, and in 50%, 63.6%, 
and 59.1% of 22 hepatocellular carcinoma specimens, respectively [14]. This means that 
everytime the Raf-1 was up-regulated, it activated the C/EBPβ pathway again that leads 
to accumulation of fat, leading to more inflammation and ultimately to cirrhosis.  
 
The other explanation that we hypothesis that there is an unknown factor in the serum, 
that is activating the MEK, leading to the activation of C/EBPβ. The next part of the 
research is to investigate these effects. 
  
23 
 
 
 
CHAPTER IV 
CONCLUSIONS 
The results from the fluorescence microscopy of the individual pathways has shown that 
with the reporter cell line generated for the purpose of this project, the transcription 
factor activity can be quantified. IL-6 and OSM have been shown to activate the C/EBPβ 
and STAT3 pathways and IL-1 has been shown to activate the C/EBPβ pathway. The 
expression of GFP (and hence, the activation of transcription factors) correlated with the 
specificity of the cytokine used. The dynamic profiles of the STAT3 and C/EBPβ 
activations obtained from the fluorescence images matched with the model derived from 
the TF calculation. 
 
Thus, the proposed model and the experimental results have been shown to be in 
excellent agreement with the experimental data set and having less than 1unit of random 
error in the fluorescence intensity. Thus, with this model of transcription factor activity, 
one can easily take into consideration any transcription factor and do a similar analysis 
of quantifying the transcription factor activity. 
 
The future work will be conducted on – 1) Test the hypothesis of Raf-1 activating the 
pathway by monitoring the activation of Raf-1 in HepG2, 2) Test the hypothesis of the 
unknown factor in serum activating MEK, ultimately leading to fat accumulation, 3) 
24 
 
 
 
Using a more potent ERK pathway inhibitor, PD184352, to investigate the imbalance in 
the transcription factor activity.  
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